FindTrial
Sign In

Levels of Klotho and FGF-23 proteins in people with Type2 Diabetes, with and without kidney complications

A cross sectional study of soluble Klotho protein and fibroblast growth factor 23 levels in nondiabetic individuals and Type 2 Diabetes Mellitus patients with and without diabetic nephropathy - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100642
Enrollment
90
Registered
2026-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E082- Diabetes mellitus due to underlying condition with kidney complications

Interventions

Intervention1: Type 2 Diabetes Mellitus with Diabetic Nephropathy: Soluble klotho and Fibroblast growth factor 23 Intervention2: Type 2 Diabetes Mellitus without Diabetic Nephropathy: Soluble Klotho a

Sponsors

Dr Rajsrimala K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age more than 18 years, all previously diagnosed type 2 diabetes mellitus patients

Exclusion criteria

Exclusion criteria: age less than 18 years, autoimmune disorders, any chronic infection, malignancy/ pregnancy, known cardiovascular hepatic disease, renal disease of non-diabetic origin

Design outcomes

Primary

MeasureTime frame
serum soluble klotho and FGF-23 levels measured by ELISATimepoint: 6 Months—

Secondary

MeasureTime frame
Renal function markers, Glycemic control markers, lipid profile, complete blood hemogram, urine albumin and creatinineTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Sudha

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, seeragapadi, Salem

sudhabharani76.sb4@gmail.com9894401792

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026